Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 454

1.

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207.

2.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN.

Ann Intern Med. 2018 Aug 21. doi: 10.7326/M18-1136. [Epub ahead of print] No abstract available.

PMID:
30140853
3.

Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.

Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

Drug Alcohol Depend. 2018 Oct 1;191:86-90. doi: 10.1016/j.drugalcdep.2018.06.028. Epub 2018 Jul 31.

4.

Xylitol for the prevention of acute otitis media episodes in children aged 2-4 years: protocol for a pragmatic randomised controlled trial.

Persaud N, Laupacis A, Azarpazhooh A, Birken C, Hoch JS, Isaranuwatchai W, Maguire JL, Mamdani MM, Thorpe K, Allen C, Mason D, Kowal C, Bazeghi F, Parkin P; and The TARGet Kids! Collaboration.

BMJ Open. 2018 Aug 5;8(8):e020941. doi: 10.1136/bmjopen-2017-020941.

5.

Usability of an Educational Intervention to Overcome Therapeutic Inertia in Multiple Sclerosis Care.

Saposnik G, Tobler PN, Caceres F, Terzaghi MA, Ruff C, Maurino J, Fruns Quintana M, Oh J, Montalban X, Mamdani M.

Front Neurol. 2018 Jul 10;9:522. doi: 10.3389/fneur.2018.00522. eCollection 2018.

6.

Second-generation anti-depressants and risk of new-onset seizures in the elderly.

Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN.

Clin Toxicol (Phila). 2018 Jul 10:1-6. doi: 10.1080/15563650.2018.1483025. [Epub ahead of print]

PMID:
29989445
7.

Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.

Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM.

PLoS Med. 2018 Jun 11;15(6):e1002584. doi: 10.1371/journal.pmed.1002584. eCollection 2018 Jun.

8.

Association between perioperative beta blocker use and cancer survival following surgical resection.

Musselman RP, Bennett S, Li W, Mamdani M, Gomes T, van Walraven C, Boushey R, Al-Obeed O, Al-Omran M, Auer RC.

Eur J Surg Oncol. 2018 Aug;44(8):1164-1169. doi: 10.1016/j.ejso.2018.05.012. Epub 2018 May 17.

PMID:
29858097
9.

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride.

Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMC Musculoskelet Disord. 2018 May 22;19(1):160. doi: 10.1186/s12891-018-2076-9.

10.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.

Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T.

Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.

11.

RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status.

Stepp WH, Farquhar D, Sheth S, Mazul A, Mamdani M, Hackman TG, Hayes DN, Zevallos JP.

JAMA Otolaryngol Head Neck Surg. 2018 Apr 18. doi: 10.1001/jamaoto.2018.0602. [Epub ahead of print]

PMID:
29710215
12.

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

J Addict Med. 2018 Apr 25. doi: 10.1097/ADM.0000000000000412. [Epub ahead of print] No abstract available.

PMID:
29697503
13.

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study.

Tadrous M, Brahmania M, Martins D, Knowles S, Janssen HLA, Mamdani MM, Juurlink DN, Gomes T.

J Manag Care Spec Pharm. 2018 May;24(5):464-468. doi: 10.18553/jmcp.2018.24.5.464.

14.

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.

Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T.

CMAJ Open. 2018 Mar 14;6(1):E132-E138. doi: 10.9778/cmajo.20170132.

15.

Online social network response to studies on antidepressant use in pregnancy.

Vigod SN, Bagheri E, Zarrinkalam F, Brown HK, Mamdani M, Ray JG.

J Psychosom Res. 2018 Mar;106:70-72. doi: 10.1016/j.jpsychores.2018.01.009. Epub 2018 Jan 17.

PMID:
29455902
16.

Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology.

Jayasundara K, Krahn M, Mamdani M, Hoch JS, Grootendorst P.

Pharmacoecon Open. 2017 Sep;1(3):167-173. doi: 10.1007/s41669-017-0022-7.

17.

Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based study.

Hussain MA, Alali AS, Mamdani M, Tu JV, Saposnik G, Salata K, Nathens AB, de Mestral C, Bhatt DL, Verma S, Al-Omran M.

J Neurosurg. 2018 Feb 2:1-8. doi: 10.3171/2017.8.JNS171142. [Epub ahead of print]

PMID:
29393758
18.

The association of exposure to suicide-related Internet content and emergency department visits in children: A population-based time series analysis.

Poonai N, Mehrotra S, Mamdani M, Patmanidis A, Miller M, Sukhera J, Doan Q.

Can J Public Health. 2018 Jan 22;108(5-6):e462-e467. doi: 10.17269/cjph.108.6079.

PMID:
29356650
19.

Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study.

Jaja BNR, Saposnik G, Lingsma HF, Macdonald E, Thorpe KE, Mamdani M, Steyerberg EW, Molyneux A, Manoel ALO, Schatlo B, Hanggi D, Hasan D, Wong GKC, Etminan N, Fukuda H, Torner J, Schaller KL, Suarez JI, Stienen MN, Vergouwen MDI, Rinkel GJE, Spears J, Cusimano MD, Todd M, Le Roux P, Kirkpatrick P, Pickard J, van den Bergh WM, Murray G, Johnston SC, Yamagata S, Mayer S, Schweizer TA, Macdonald RL; SAHIT collaboration.

BMJ. 2018 Jan 18;360:j5745. doi: 10.1136/bmj.j5745.

20.

Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study.

Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T.

Can Urol Assoc J. 2018 Mar;12(3):E142-E145. doi: 10.5489/cuaj.4541. Epub 2017 Dec 22.

Supplemental Content

Loading ...
Support Center